Menta Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-21,406
Closed -$1.82M 1054
2016
Q1
$1.82M Sell
21,406
-11,100
-34% -$826K 0.25% 77
2015
Q4
$2.57M Sell
32,506
-9,900
-23% -$780K 0.33% 49
2015
Q3
$2.98M Buy
42,406
+17,100
+68% +$1.41M 0.47% 14
2015
Q2
$2.28M Buy
25,306
+9,700
+62% +$935K 0.37% 49
2015
Q1
$1.57M Sell
15,606
-860
-5% -$86.7K 0.2% 167
2014
Q4
$1.66M Buy
16,466
+4,566
+38% +$455K 0.23% 124
2014
Q3
$1.15M Buy
+11,900
New +$1.13M 0.19% 158
2014
Q1
Sell
-2,500
Closed -$209K 495
2013
Q4
$209K Buy
+2,500
New +$204K 0.09% 302
2013
Q3
Sell
-9,700
Closed -$769K 499
2013
Q2
$769K Buy
+9,700
New +$778K 0.49% 33

Other funds holding MJN

Menta Capital's MJN Position: Q2 2016 in Review

Menta Capital sold out of Mead Johnson Nutrition Company (MJN) in Q2 2016, closing a stake of 21,406 shares — an estimated $1.82M sold.

Menta Capital first reported a position in MJN in Q2 2013 and held it in 9 quarters. The position peaked at $2.98M in Q3 2015. 545 funds tracked by Wall St. Rank hold MJN as of Q2 2016.

  • Menta Capital reported no remaining Mead Johnson Nutrition Company position as of Q2 2016 after selling out during the quarter.
  • Menta Capital sold 21,406 Mead Johnson Nutrition Company shares in Q2 2016, an estimated $1.82M.
  • Menta Capital first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 9 quarters.
  • Menta Capital's Mead Johnson Nutrition Company position peaked at $2.98M in Q3 2015.
  • 545 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2016.

Based on Menta Capital's 13F filing for Q2 2016, filed 12 Aug 2016.